All In Biotech

Free tool

FAERS Monitor: Furoscix

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209988 or its brand name (Furoscix, Furosemide). Reports on generic versions are filed under their own applications.

Reports

265,818

Serious

219,295

82% of reports

Hospitalization

129,814

Death reported

40,890

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • dyspnoea18,448
  • acute kidney injury16,469
  • fatigue13,255
  • diarrhoea13,197
  • death12,375
  • nausea11,538
  • fall11,004
  • off label use10,843
  • drug ineffective10,454
  • hypotension10,334
  • pneumonia10,173
  • dizziness9,893
  • asthenia9,290
  • headache8,713
  • pain8,201

Reports by year received

View as table
YearReports
20043,479
20053,857
20063,623
20073,214
20083,608
20093,997
20104,832
20116,479
20127,274
20137,405
201410,059
201513,254
201616,201
201716,716
201821,192
201923,004
202020,355
202118,734
202216,306
202316,501
202417,514
202516,349
202611,858

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,788,341 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
acute kidney injurySignal16,4699.49.3111,433
hypotensionSignal10,3344.24.224,529
fallSignal11,0042.72.611,304
dyspnoeaSignal18,4482.62.618,553
pneumoniaSignal10,1732.52.59,295
asthenia9,2902.01.94,468
diarrhoea13,1971.61.63,251
dizziness9,8931.61.62,120
fatigue13,2551.41.31,247
nausea11,5381.21.1248
death12,3751.11.1214
headache8,7131.11.182
pain8,2011.11.026
off label use10,8431.01.05
drug ineffective10,4540.60.62,495

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.